25-10-2021 | Rheumatology | News | Article
Herpes zoster rates elevated with upadacitinib in RA
Individuals with rheumatoid arthritis receiving the oral Janus kinase inhibitor upadacitinib have higher rates of herpes zoster than those being treated with methotrexate alone or in combination with adalimumab, research shows.
05-10-2021 | Rheumatology | News | Article
Denosumab benefits short-lived following discontinuation
Discontinuing denosumab after 1 year of treatment quickly leads to reversal of its inhibitory effect on bone turnover markers and improvements in bone mineral density among people using glucocorticoids for rheumatoid arthritis, research shows.
Coronavirus illustration with dark blue cell background/© peterschreiber.media / Getty Images / iStock, Kidneys/© psdesign1 / fotolia.com , Blood sample_lupus/© Victor Moussa / stock.adobe.com